CYTEK BIOSCIENCES, INC. Marketing and Advertising Expense
CYTEK BIOSCIENCES, INC. (CTKB) reported Marketing and Advertising Expense of $1.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:MarketingAndAdvertisingExpense · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. marketing and advertising expense for the quarter ending 2026-06-30 was $1.70M, a 41.67% increase year-over-year.
- CYTEK BIOSCIENCES, INC. marketing and advertising expense for the quarter ending 2026-03-31 was $900.00K, a 25.00% decline year-over-year.
- CYTEK BIOSCIENCES, INC. marketing and advertising expense for the quarter ending 2025-12-31 was $1.00M, a 25.00% increase year-over-year.
- CYTEK BIOSCIENCES, INC. marketing and advertising expense for the quarter ending 2025-09-30 was $800.00K, a 0.00% change year-over-year.
- CYTEK BIOSCIENCES, INC. marketing and advertising expense for fiscal 2025 was $4.20M, a 10.53% increase from fiscal 2024.
- CYTEK BIOSCIENCES, INC. marketing and advertising expense for fiscal 2024 was $3.80M, a 11.76% increase from fiscal 2023.
- CYTEK BIOSCIENCES, INC. marketing and advertising expense for fiscal 2023 was $3.40M, a 36.00% increase from fiscal 2022.
- CYTEK BIOSCIENCES, INC. marketing and advertising expense for fiscal 2022 was $2.50M, a 38.89% increase from fiscal 2021.
| Period end | Marketing and Advertising Expense 3 month | Marketing and Advertising Expense 3 month as first filed | Marketing and Advertising Expense 6 month | Marketing and Advertising Expense 6 month as first filed | Marketing and Advertising Expense 9 month | Marketing and Advertising Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.70M 10-Q · filed 2026-08-05 | $2.60M 10-Q · filed 2026-08-05 | $3.60M derived: sum of 3 quarters · filed 2026-08-05 | $4.40M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $900.00K 10-Q · filed 2026-05-07 | $1.90M derived: sum of 2 quarters · filed 2026-05-07 | $2.70M derived: sum of 3 quarters · filed 2026-05-07 | $3.90M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.80M derived: sum of 2 quarters · filed 2026-02-26 | $3.00M derived: sum of 3 quarters · filed 2026-08-05 | $4.20M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $800.00K 10-Q · filed 2025-11-05 | $2.00M derived: sum of 2 quarters · filed 2026-08-05 | $3.20M 10-Q · filed 2025-11-05 | $4.00M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $1.20M 10-Q · filed 2026-08-05 | $2.50M 10-Q · filed 2026-08-05 | $3.20M derived: sum of 3 quarters · filed 2026-08-05 | $4.00M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $1.20M 10-Q · filed 2026-05-07 | $2.00M derived: sum of 2 quarters · filed 2026-05-07 | $2.80M derived: sum of 3 quarters · filed 2026-05-07 | $4.10M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.60M derived: sum of 2 quarters · filed 2026-02-26 | $2.90M derived: sum of 3 quarters · filed 2026-02-26 | $3.80M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $800.00K 10-Q · filed 2025-11-05 | $2.10M derived: sum of 2 quarters · filed 2025-11-05 | $3.00M 10-Q · filed 2025-11-05 | $3.70M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $1.30M 10-Q · filed 2025-08-06 | $2.20M 10-Q · filed 2025-08-06 | $2.90M derived: sum of 3 quarters · filed 2026-02-26 | $3.40M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $900.00K 10-Q · filed 2025-05-08 | $1.60M derived: sum of 2 quarters · filed 2026-02-26 | $2.10M derived: sum of 3 quarters · filed 2026-02-26 | $3.40M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.20M derived: sum of 2 quarters · filed 2026-02-26 | $2.50M derived: sum of 3 quarters · filed 2026-02-26 | $3.40M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $500.00K 10-Q · filed 2024-11-07 | $1.80M derived: sum of 2 quarters · filed 2024-11-07 | $2.70M 10-Q · filed 2024-11-07 | $3.60M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-06-30 | $1.30M 10-Q · filed 2024-08-06 | $2.10M 10-Q · filed 2024-08-06 | $3.10M derived: sum of 3 quarters · filed 2025-02-28 | $3.60M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-03-31 | $900.00K 10-Q · filed 2023-05-09 | $1.80M derived: sum of 2 quarters · filed 2025-02-28 | $2.30M derived: sum of 3 quarters · filed 2025-02-28 | $3.10M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2022-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.40M derived: sum of 2 quarters · filed 2025-02-28 | $2.20M derived: sum of 3 quarters · filed 2025-02-28 | $2.50M 10-K · filed 2025-02-28 | ||
| 2022-09-30 | $500.00K 10-Q · filed 2023-11-14 | $1.30M derived: sum of 2 quarters · filed 2023-11-14 | $1.60M 10-Q · filed 2023-11-14 | $2.30M derived: sum of 4 quarters · filed 2024-03-13 | ||
| 2022-06-30 | $800.00K 10-Q · filed 2023-08-08 | $1.10M 10-Q · filed 2023-08-08 | $1.80M derived: sum of 3 quarters · filed 2024-03-13 | $2.30M derived: sum of 4 quarters · filed 2024-03-13 | ||
| 2022-03-31 | $400.00K 10-Q · filed 2023-05-09 | $1.00M derived: sum of 2 quarters · filed 2024-03-13 | $1.50M derived: sum of 3 quarters · filed 2024-03-13 | $1.90M derived: sum of 4 quarters · filed 2024-03-13 | ||
| 2021-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $1.10M derived: sum of 2 quarters · filed 2024-03-13 | $1.50M derived: sum of 3 quarters · filed 2024-03-13 | $1.80M 10-K · filed 2024-03-13 | ||
| 2021-09-30 | $500.00K 10-Q · filed 2022-11-09 | $513.00K 10-Q · filed 2021-11-12 | $900.00K derived: sum of 2 quarters · filed 2022-11-09 | $1.20M 10-Q · filed 2022-11-09 | $1.40M derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | $400.00K 10-Q · filed 2022-08-10 | $449.00K 10-Q · filed 2021-09-03 | $600.00K 10-Q · filed 2022-08-10 | $646.00K 10-Q · filed 2021-09-03 | $895.00K derived: sum of 3 quarters · filed 2022-08-10 | $1.11M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $200.00K 10-Q · filed 2022-05-12 | $495.00K derived: sum of 2 quarters · filed 2022-05-12 | $710.00K derived: sum of 3 quarters · filed 2022-05-12 | $887.00K derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $295.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $510.00K derived: sum of 2 quarters · filed 2022-03-17 | $687.00K derived: sum of 3 quarters · filed 2022-03-17 | $1.00M 10-K · filed 2022-03-17 | ||
| 2020-09-30 | $215.00K 10-Q · filed 2021-11-12 | $392.00K derived: sum of 2 quarters · filed 2021-11-12 | $705.00K 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | $177.00K 10-Q · filed 2021-09-03 | $489.00K 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |